KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,225,603 | +169.7% | 1,660,898 | +260.2% | 0.00% | +200.0% |
| Q2 2023 | $825,362 | -42.6% | 461,096 | +24.8% | 0.00% | -50.0% |
| Q1 2023 | $1,437,763 | -0.2% | 369,605 | -12.8% | 0.00% | 0.0% |
| Q4 2022 | $1,440,308 | -100.0% | 423,620 | -44.4% | 0.00% | -71.4% |
| Q3 2022 | $4,163,359,000 | +58.0% | 762,520 | +30.5% | 0.01% | +75.0% |
| Q2 2022 | $2,635,139,000 | +4081.8% | 584,288 | +6733.8% | 0.00% | – |
| Q1 2022 | $63,014,000 | -32.1% | 8,550 | -40.7% | 0.00% | – |
| Q4 2021 | $92,746,000 | -96.6% | 14,424 | -96.9% | 0.00% | -100.0% |
| Q3 2021 | $2,725,163,000 | -32.8% | 468,241 | +19.2% | 0.00% | -20.0% |
| Q2 2021 | $4,052,994,000 | +4266.1% | 392,732 | +4350.7% | 0.01% | – |
| Q1 2021 | $92,828,000 | -93.7% | 8,824 | -90.7% | 0.00% | -100.0% |
| Q4 2020 | $1,474,965,000 | +522.1% | 95,282 | +486.7% | 0.00% | – |
| Q3 2020 | $237,104,000 | +18.0% | 16,240 | +53.0% | 0.00% | – |
| Q2 2020 | $201,010,000 | -71.9% | 10,613 | -71.5% | 0.00% | -100.0% |
| Q1 2020 | $714,420,000 | +437.1% | 37,190 | +436.0% | 0.00% | – |
| Q4 2019 | $133,021,000 | +69.3% | 6,939 | -15.0% | 0.00% | – |
| Q3 2019 | $78,557,000 | +141.7% | 8,166 | +50.5% | 0.00% | – |
| Q2 2019 | $32,508,000 | -45.2% | 5,427 | -46.6% | 0.00% | – |
| Q1 2019 | $59,358,000 | +105896.4% | 10,164 | +169300.0% | 0.00% | – |
| Q4 2018 | $56,000 | -99.8% | 6 | -99.6% | 0.00% | – |
| Q3 2018 | $27,197,000 | +0.2% | 1,597 | 0.0% | 0.00% | – |
| Q2 2018 | $27,133,000 | -74.4% | 1,597 | -79.8% | 0.00% | – |
| Q1 2018 | $105,978,000 | +55.0% | 7,897 | +10.9% | 0.00% | – |
| Q4 2017 | $68,381,000 | +43.1% | 7,123 | +63.7% | 0.00% | – |
| Q3 2017 | $47,785,000 | +18.7% | 4,352 | -2.1% | 0.00% | – |
| Q2 2017 | $40,245,000 | +215.3% | 4,447 | +347.4% | 0.00% | – |
| Q1 2017 | $12,763,000 | +0.9% | 994 | -26.1% | 0.00% | – |
| Q4 2016 | $12,643,000 | -26.1% | 1,345 | -23.5% | 0.00% | – |
| Q3 2016 | $17,115,000 | +174.3% | 1,759 | +89.1% | 0.00% | – |
| Q2 2016 | $6,240,000 | -89.7% | 930 | -79.7% | 0.00% | – |
| Q4 2015 | $60,738,000 | +12.2% | 4,584 | -10.9% | 0.00% | – |
| Q3 2015 | $54,145,000 | +3.5% | 5,142 | +167.5% | 0.00% | – |
| Q2 2015 | $52,298,000 | +479.2% | 1,922 | +551.5% | 0.00% | – |
| Q1 2015 | $9,030,000 | -70.5% | 295 | -66.3% | 0.00% | – |
| Q3 2014 | $30,573,000 | +1831.3% | 875 | +2473.5% | 0.00% | – |
| Q2 2014 | $1,583,000 | +145.8% | 34 | +41.7% | 0.00% | – |
| Q1 2014 | $644,000 | -70.7% | 24 | -75.0% | 0.00% | – |
| Q4 2013 | $2,200,000 | – | 96 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |